...
首页> 外文期刊>Acta medica Iranica. >PREVALENCE OF AUTOANTIBODIES TO THYROID PEROXIDASE AND AUTOIMMUNE THYROID DISEASE IN TYPE I DIABETES MELLITUS
【24h】

PREVALENCE OF AUTOANTIBODIES TO THYROID PEROXIDASE AND AUTOIMMUNE THYROID DISEASE IN TYPE I DIABETES MELLITUS

机译:Ⅰ型糖尿病患者甲状腺过氧化物酶和自身免疫性甲状腺疾病的自身抗体患病率

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Type I diabetes mellitus (DM) is frequently associated with autoimmune thyroid disease (ATD). Association of ATD and type I DM has been described with varying frequencies but there is still debate about the situation in the Iranian population. We investigated the prevalence of anti thyroid peroxidase (anti-TPO) antibodies and ATD in children and adolescents with type I DM. A total of 145 patients with type I DM were participated in this study. They were screened for anti-TPO antibodies and TSH levels. Signs and symptoms of hypothyroidism and hyperthyroidism and the presence of goiter were sought. A group of 50 healthy unrelated girls and boys aged 11-16 years served as controls. Anti-TPO antibodies were found in 34 (23.4%) diabetic patients and 1 subject (2%) in the control group (P<0.001). Frequency of anti TPO antibodies was significantly higher in girls than boys (P<0.05). We failed to show any significant correlation between thyroid autoimmunity and duration of DM. We found that younger patients at diagnosis are more likely to be anti-TPO negative (P<0.001). Out of 145 diabetic patients, 32 (22%) had visible goiter. Subclinical hypothyroidism, hypothyroidism and thyrotoxicosis occurred in 1, 9 and 1 patients, respectively. Visible goiter was found in 2 subjects (4%) of the control group, but all of them were euthyroid. In conclusion, the evaluation of thyroid autoimmunity in type I diabetic patients may improve the diagnosis of thyroid disease in early stages. Yearly examination of anti-TPO antibodies allows identifying diabetic patients with thyroid autoimmunity.
机译:I型糖尿病(DM)通常与自身免疫性甲状腺疾病(ATD)相关。人们已经以不同的频率描述了ATD与I型DM的关联,但是关于伊朗人口的情况仍存在争议。我们调查了I型DM儿童和青少年中抗甲状腺过氧化物酶(anti-TPO)抗体和ATD的患病率。共有145位I型DM患者参加了这项研究。筛选他们的抗TPO抗体和TSH水平。寻找甲状腺功能减退和甲亢的体征和症状以及甲状腺肿的存在。一组50名年龄在11-16岁之间的健康无关的男孩和女孩作为对照。对照组中有34名(23.4%)糖尿病患者和1名受试者(2%)发现抗TPO抗体(P <0.001)。女孩中抗TPO抗体的频率显着高于男孩(P <0.05)。我们未能显示出甲状腺自身免疫与糖尿病持续时间之间的任何显着相关性。我们发现,诊断时年轻的患者更有可能是抗TPO阴性的(P <0.001)。在145位糖尿病患者中,有32位(22%)患有可见甲状腺肿。亚临床甲状腺功能减退症,甲状腺功能减退症和甲状腺毒症分别发生在1、9和1例患者中。在对照组的2名受试者(4%)中发现了可见的甲状腺肿,但他们都是甲状腺功能正常的。总之,评估I型糖尿病患者的甲状腺自身免疫性可能会改善早期甲状腺疾病的诊断。每年检查抗TPO抗体可确定患有甲状腺自身免疫性疾病的糖尿病患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号